Vanguard Capital Management’s Prothena PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.88M Sell
462,553
-17,392
-4% -$155K ﹤0.01% 3161
2026
Q2
$4.7M Sell
479,945
-4,181
-0.9% -$41.3K ﹤0.01% 3147
2026
Q1
$4.71M Buy
+484,126
New +$4.44M ﹤0.01% 3089

Other funds holding PRTA

Vanguard Capital Management's PRTA Position: Q3 2026 in Review

Vanguard Capital Management reduced its Prothena (PRTA) stake by 3.6% in Q3 2026, selling an estimated $155K and leaving 462,553 shares worth $3.88M. The position accounts for ﹤0.01% of the portfolio, ranked #3161.

Vanguard Capital Management first reported a position in PRTA in Q1 2026 and has held it in 3 quarters since. The position peaked at $4.71M in Q1 2026. 182 funds tracked by Wall St. Rank hold PRTA as of Q3 2026.

  • Vanguard Capital Management held 462,553 shares of Prothena worth $3.88M as of Q3 2026.
  • Vanguard Capital Management sold 17,392 Prothena shares in Q3 2026, an estimated $155K.
  • Prothena made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #3161 holding.
  • Vanguard Capital Management first reported a position in Prothena in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Capital Management's Prothena position peaked at $4.71M in Q1 2026.
  • 182 funds tracked by Wall St. Rank held Prothena as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.